# Optiray 350

NDC: 0019-1333
Generic name: Ioversol
Labeler / Manufacturer: Liebel-Flarsheim Company LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRA-ARTERIAL, INTRAVENOUS
Marketing started: 20201118

FDA application: NDA020923

## Active ingredients

- IOVERSOL: 741 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0019-1333"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0019-1333
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd718d1c-f813-4114-a50d-c744ff7eb1bf